SUMMARY Twenty patients with mixed connective tissue disease were followed for 5 years. Arthritis occuured in all 20 patients, being the presenting complaint in 11 patients. The joints most frequently involved were the proximal interphalangeal (PIP), metacarpophalangeal (MCP), wrists, metatarsophalangeal (MTP), and knee; the distribution tended to be symmetrical, mimicking early rheumatoid arthritis. Joint deformities occurred in 6 patients, but apart from 1 patient with arthritis mutilans, significant functional impairment was not encountered. Radiologically small punched out bone erosions, asymmetrically distributed, were the most characteristic finding; other notable changes were aseptic necrosis, tuft erosions, and periarticular calcification. Joint effusions were noninflammatory, the cellular content was predominantly lymphocytic and the C3 level was normal. Most cases were controlled with non-steroidal anti-inflammatory agents and invariably responded to prednisone .7 * 5 mg/day.
In 1972 Sharp and his co-workers (Sharp et al., 1972) described an overlap syndrome of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and polymyositis which they considered a distinct rheumatic disease syndrome giving it the name 'mixed connective tissue disease' (MCTD). The unifying feature of this group of patients was the presence of antibodies to a saline soluble nuclear antigen (ENA), which was RNAse sensitive. Subsequent work has resolved ENA into two distinct moieties which are probably covalently linked: soluble ribonucleoprotein (RNP) and a glycoprotein termed Sm antigen (Mattioli and Reichlin, 1977) . RNAse sensitive ENA is synonymous with RNP. Antibodies to RNP are a sine qua non for the diagnosis of MCTD, albeit not specific, being found in a small proportion of patients with classical scleroderma and SLE (Reichlin and Mattioli, 1972; Parker, 1973; Sharp et al., 1976) .
More recent studies have indicated that anti-Sm antibodies are restricted to patients with SLE (Notman et al., 1975) . The concept of MCTD as a distinct clinical entity has not been generally accepted. It has been suggested that the MCTD syndrome is most compatible with SLE favourably modified by Accepted for publication January 11, 1978 Correspondence to Dr Robert M. Bennett, Division of Immunology, Allergy and Rheumatology, University of Oregon Health Sciences Center, 3181 S. W. Sam Jackson Park Road, Portland, Oregon 97201, USA the presence of RNP antibodies (Reichlin and Mattioli, 1974; Reichlin, 1976) . In the initial report of MCTD serious complications, as found in SLE, were conspicuously lacking. However, subsequent experience has led to the recognition of both renal disease (Bennett and Spargo, 1977a; Fuller et al., 1977) and neuropsychiatric problems (Bennett and Spargo, 1977b) . Arthralgias and arthritis have been the commonest clinical finding (Sharp et al., 1972; Reichlin, 1976) . Indeed the most frequent initial diagnosis in our series of patients was early rheumatoid arthritis (RA) or juvenile rheumatoid arthritis (JRA). This present study reports on the articular manifestations in 20 patients with MCTD each followed for 5 years.
Patients and methods
The criteria applied for the diagnosis of MCTD were: (1) a speckled pattern of antinuclear immunofluorescence > 1:480; (2) RNAse sensitive ENA haemagglutination titre >1:6400; (3) persistently absent antibodies to double stranded DNA (dsDNA) and Sm antigens; (4) sequential or concurrent clinical 'overlap' of features seen in SLE, PSS, RA, and polymyositis.
ENA was prepared according to the procedure described by Sharp et al., (1972) . with the exception that calf thymus nuclei were isolated in 2-2 mol/l sucrose, 1 mmol/l MgCl2, as outlined by Chauveau et al. (1956) .
Tanning and sensitisation of human group 0 red blood cells were performed as previously described (Eddie-Quartey and Bennett, 1973) (Kurata and Tan, 1976) .
Antibodies to dsDNA were assayed by a modified Farr technique as previously described (Bennett and Molina, 1976) . The purity of the dsDNA, in terms of small single stranded regions, was monitored by benzoylated, naphthoylated DEAE cellulose chromotography and S1 endonuclease digestion as we have previously outlined (Locker et al., 1977) . The dsDNA used to assay the patient's sera was less than 3 % contaminated with single stranded regions; sera from normals and rheumatoid diseases other than SLE, bound less than 0-5 jig of dsDNA/ml serum. Skeletal x-rays were obtained with fine detail film as previously described by Genant et al. (1976) .
Results
The (Ropes et al., (1959) , omitting 'exclusion diagnoses', 12 patients could be classified as having classical RA. On the other hand, utilising the preliminary criteria for the diagnosis of SLE, 16 (80%) patients could equally well be labelled with this diagnosis (Cohen et al., 1971) . If a high titre of antinuclear immunofluorescence is substituted for a positive LE cell preparation as previously suggested (Trimble et al., 1974) , all 20 patients satisfy the criteria for SLE. These findings are summarised in Table 3 bilateral hips, one knee, and both pedal naviculars. Two of these patients had been on prednisone 12.5 mg/day and 10 mg/day at the onset of the aseptic necrosis. In another 2 instances asymptomatic aseptic necrosis was seen at radiography, involving both carpal naviculars in 1 patient and a medullary bone infarct shaft of the right humerus in another.
In the majority of patients joint symptoms could be adequately controlled with non-steroidal antiinflammatory agents. Three patients required low dose steroids, prednisone 5 mg to 7.5 mg, to achieve a satisfactory control of joint inflammation.
HISTOLOGY
Proliferative synovitis was not a conspicuous feature of the arthritis in most patients. The patient with arthritis mutilans underwent fusion of the right wrist and a specimen of bone and synovium was obtained at operation (Fig. 4) . There was synovial cell proliferation with a chronic inflammatory cell infiltrate without any follicle formation. Cartilage had been completely destroyed.
LABORATORY FINDINGS
As previously defined, all patients studied had RNP antibodies in a titre of .1:6400, a speckled pattern of antinuclear immunofluorescent >1:480, and persistently absent antibodies to dsDNA and the Sm antigen The titre of RNP antibodies did not correlate either positively or negatively with the extent of active joint inflammation or other manifestations of disease activity.
Rheumatoid factor was present in 5 patients. The highest values (SCAT 1:5120 and 1:1280) were seen in 2 patients with a disease most consistent with PSS; one of these patients had ulnar deviation and minor erosive changes radiologically. In the 3 patients whose 'follow-up' diagnosis was most There is a complete loss of cartilage with synovial erosion ofbone; the synovial membrane is greatly hypertrophied with increased vascularity and is infiltrated with mononuclear cells. compatible with rheumatoid arthritis, rheumatoid factor was persistently absent from their sera.
An elevated erythrocyte sedimentation rate was encountered in all patients at some time in the course of their disease; it tended to be related to systemic manifestations of MCTD rather than the joint involvement.
An anaemia of chronic inflammation was found in 75 % of patients and this usually correlated with a hypergammaglobulinaemia. A reduced serum C4 level was seen in 30% of patients, the reduction tended to be a transient and sometimes fluctuating phenomena not obviously related to disease activity.
Only 2 specimens of synovial fluid were obtained; in both cases there was a good viscosity and normal mucin clot, white cells were 2500/mm3 (2.5 x 109/l lymphocytes 90 %) and 7500/mm3 (7.5 x 109/1 lymphocytes 70%.), respectively. C3 levels were normal relative to synovial fluid protein concentration.
RADIOLOGICAL FEATURES
Fine detail films of the hands and feet were obtained of all 20 patients. Twelve cases had periarticular erosions in the small bones of the hands and feet. The erosions tended to be few in number and were small and asymmetrically distributed (Figs. 5 and 6). In 2 of these 12 cases, the only abnormality was an isolated erosion in the base of the phalanx or in the styloid process of the ulna. Associated soft tissue swelling was seen in all 12 of the patients with bone erosions. Two cases had a severe destructive arthritis with extensive resorption of bone in the carpus and fingers. The pattern of bone destruction resembled psoriatic arthritis. (Fig. 7) Joint space narrowing was unusual and was seen in only 2 patients, both of whom had a mild erosive arthritis. The bone density in the hands and feet tended to be well preserved, even in the patients with bone erosions. Generalised osteopoenia was appreciated in 4 patients, 2 of whom had a severe erosive arthritis. The other 2 had multiple subluxations of the metacarpophalangeal joints with ulnar deviations (Fig. 8) . X-rays of these latter 2 cases resembled the pattern associated with SLE. In 3 patients, all of whom had metacarpophalangeal and interphalangeal erosions, there were additional erosions in the tufts of the distal phalanges with associated pulp atrophy.
Periarticular calcification around the carpus and several interphalangeal joints was the only abnormality in 1 case.
Avascular necrosis of bone occurred in 5 patients. There was a symmetrical involvement of the hips 7 i; 
Discussion
Within the rheumatic diseases the diagnosis of well established rheumatoid arthritis, progressive systemic sclerosis, dermatomyositis, and systemic lupus erythematosus is usually clearcut. However, the initial manifestations of general malaise, arthralgias, and vascular instability are deceptively similar; a definitive diagnosis usually depending upon a period of careful follow-up to detect a characteristic evolution of physical findings, laboratory tests, and radiological changes. It is the experience of most rheumatologists that at the outset there may be several features characteristic of more than one rheumatic disease, or sometimes during the course of the disease, there may be a progression of one rheumatic disease syndrome into another. Such 'overlap' syndromes have been described for scleroderma and dermatomyositis (Tuffanelli and Winkelmann et al., 1961; Clark et al., 1971) , rheumatoid arthritis and scleroderma (Tuffanelli and Winkelmann et al., 1961; Poirer and Rankin, 1972) , SLE and polymyositis (Keil, 1940; Estes and Christian, 1971; Dubois, 1973) , rheumatoid arthritis and SLE (Haserick, 1955; Sigler et al., 1958; Toone et al., 1960; Dubois 1962; Dubois, 1974) , and scleroderma and SLE (Muehrcke et al., 1957; Tuffanelli and Winkelmann, 1961; Rowell, 1962; D'Angelo et al., 1969; Dubois, et al., 1971; Poirer and Rankin, 1972; Dubois, 1974) . Whether such associations represent the co-existence of separate diseases, distinct clinical entities, or the more widespread expression of a single rheumatic disease syndrome, has been a source of some controversy.
Lacking well defined aetiological factors, one rationale for the present classification of rheumatic diseases is to aid in planning effective treatment and to provide some estimate of prognosis. In this respect it would seem justifiable to consider MCTD a distinct rheumatic disease syndrome. The prognosis of MCTD is usually good, although renal disease (Bennett and Spargo, 1977a; Fuller et al., 1977) and central nervous system involvement (Bennett and Spargo, 1977b ) must now be included in the clinical spectrum. However, such major organ involvement, is generally mild in comparison to classical SLE, and is responsive to relatively small amounts of corticosteroids.
This present study indicates that the arthritis of MCTD is also relatively benign in the majority of cases.
Arthritis was the commonest clinical presentation of MCTD, in over half our patients the initial diagnosis was rheumatoid arthritis or juvenile rheumatoid arthritis. This is similar to the experience of other workers (Sharp et al., 1972; Parker, 1973; Reichlin, 1976; Leibfarth and Persellin, 1976; Sharp et al., 1976) including the onset in childhood (Singsen et al., 1977) . The pattern of joint involvement was compatible with a diagnosis of rheumatoid arthritis, but the long term follow-up was unusual in several respects. Even after many years of disease activity joint deformities occurred in only 7 patients. and except for 1 patient with arthritis mutilans, none of the other patients suffered impaired locomotor function. In patients with disease most closely resembling rheumatoid arthritis the rheumatoid factor was persistently negative on long-term follow-up. Except for the case of arthritis mutilans, severe erosive disease was not seen radiologically. However, 12 patients did exhibit minor erosive changes in the hands and feet; these were characterised by an asymmetrical distribution and an appearance best described as small, punched out bone erosions (see Figs. 5 and 6) . We believe these radiological findings should suggest a possible diagnosis of MCTD (O'Connell and Bennett, 1977) . The patient with arthritis mutilans had co-existent discoid LE and radiologically had 'pencil-in-cup' deformities resembling psoriatic arthritis (see Fig. 7 ), another patient had similar radiological changes in the toes. These psoriatic-like radiological appearances have been described previously in 1 patient with scleroderma (Wild and Beetham, 1975) . We are not aware of a severe destructive arthritis being reported in association with discoid LE. An erosive arthritis of minor degree has been sporadically reported in association with polymyositis (Bunch et al., 1976) , SLE (Noonan et al., 1963) , and PSS (Rabinowitz et al., 1974) . Whether the patients described in these latter reports had what we would now call MCTD is not apparent from the clinical and laboratory data given. It is evident that minor erosive disease will occur, as a reaction to prolonged contiguous synovial inflammation, without respect for our attempts at an orderly classification of disease.
Analysis of our patients with MCTD favours the concept that it represents a relatively undifferentiated rheumatic disease with a propensity for a sequential and sometimes concurrent development of features consistent with SLE, PSS, polymyositis, and rheumatoid arthritis (R. M. Bennett, R. H. Riddell, D. J. O'Connell, and B. H. Spargo, unpublished data). We suggest that a high titre of RNP antibodies and absent antibodies to dsDNA and Sm antigen, characterise a group of patients with a pluropotentiality in their expression of rheumatic disease.
Joint pain is the commonest initial complaint in the undifferentiated phase of MCTD and is seen to mimic the early non-specific articular involvement of other rheumatic diseases. An increasing awareness of this clinical presentation, coupled with appropriate serological tests, would help to establish the true prevalence of MCTD and resolve the controversy regarding its nosology.
